(NYSE MKT:KIQ),(TSX:KLS), WEST KELOWNA, British Columbia and BONHAM, Texas , Aug. 13, 2025 (GLOBE NEWSWIRE) — Kelso Technologies Inc. (TSX: KLS) (“Kelso” or the “Company”) announces that Lead Director Paul Cass will retire from the Board of Directors on August 31, 2025. Independent Director Jesse Crews will assume the role of Lead Director starting September […]

(NasdaqGM:ACRV), Continued advancement of two clinical-stage assets, both with clinically demonstrated single-agent anti-tumor activity — ACR-368 in a registrational-intent Phase 2 study in endometrial cancer and ACR-2316 in a Phase 1 study in AP3-predicted tumor types New paradigm for accelerated design and development of novel compounds, like ACR-2316, based on optimal intracellular pathway selectivity, uniquely

(NasdaqGM:FIGXU), Tiburon, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) — FIGX Capital Acquisition Corp. (Nasdaq: FIGXU) (the “Company“) announced today that, commencing August 18, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants

(NasdaqGM:ALVO),(Nasdaq First North Iceland:ALVO),(Stockholm:ALVO SDB), Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech's history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market Conference call and live webcast on Thursday August 14, 2025, 8:00 am ET (12:00pm

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update GlobeNewswire August 13, 2025 Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech's history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors GlobeNewswire August 13, 2025 NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that Henry Fernandez, its Lead Independent Director, has stepped down from its Board of Directors, effective August 13, 2025. Mr. Fernandez joined the Royalty Pharma Board

Dillard's, Inc. to Report Second Quarter and Year-to-Date Results GlobeNewswire August 13, 2025 LITTLE ROCK, Ark., Aug. 13, 2025 (GLOBE NEWSWIRE) — Dillard's, Inc. (DDS: NYSE) will announce results for the 13 and 26 weeks ended August 2, 2025 tomorrow before the open of the New York Stock Exchange. Contact: Julie J. GuymonDirector of Investor

KBR Awarded an Estimated $2.459 Billion Contract to Support Astronaut Health and Performance for Space Missions GlobeNewswire August 13, 2025 HOUSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) announced today it has been awarded an estimated $2.459 billion NASA contract to support astronaut health, occupational health, and research that could help mitigate health

Kelso Technologies Inc. Announces Director Retirement GlobeNewswire August 13, 2025 WEST KELOWNA, British Columbia and BONHAM, Texas , Aug. 13, 2025 (GLOBE NEWSWIRE) — Kelso Technologies Inc. (TSX: KLS) (“Kelso” or the “Company”) announces that Lead Director Paul Cass will retire from the Board of Directors on August 31, 2025. Independent Director Jesse Crews will

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire August 13, 2025 Continued advancement of two clinical-stage assets, both with clinically demonstrated single-agent anti-tumor activity — ACR-368 in a registrational-intent Phase 2 study in endometrial cancer and ACR-2316 in a Phase 1 study in AP3-predicted tumor types New paradigm for accelerated design